Skip to content

Construction and effect evaluation of exercise intervention scheme for cancer chemotherapy patients

Construction and effect evaluation of exercise intervention scheme for cancer chemotherapy patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107928
Enrollment
Unknown
Registered
2025-08-21
Start date
2024-03-23
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related symptoms and chemotherapy-related side effects

Interventions

Sponsors

Fujian Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=18 years old; know their own disease diagnosis, condition, treatment and prognosis; 2. Diagnosis of cancer (pathology); Planned implementation of a conventional chemotherapy regimen (with or without biologics); 3. ECOG score 0--2 points; 4. Informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. Diagnosed by a doctor with special types of sleep disorders, such as narcolepsy, nocturnal lower limb cramps, sleep aphalation disorders, or delusions; 2. Severe anemia, bone marrow suppression or extensive metastasis is not tolerated; Patients with severe physical mobility limitations and need to rest in bed; 3. Those with dementia, cognitive or mental disorders, or those with physical dysfunction who cannot cooperate; 4. Combined with severe hypertension, coronary heart disease and asthma; 5. There are contraindications to exercise, and the physician in charge deems it unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
chemotherapy-related cognitive impairment;Anxiety;sleep quality;depression;

Secondary

MeasureTime frame
quality of life;Health-related physical fitness;

Countries

China

Contacts

Public ContactLin Yan

Fujian Cancer Hospital

2286181792@qq.com+86 591 83660063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026